Skip to main content
Log in

Impaired TNFα-induced VEGF Expression in Human Airway Smooth Muscle Cells from Smokers with COPD: Role of MAPkinases and Histone Acetylation—Effect of Dexamethasone

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

The cytokine and potent angiogenic factor vascular endothelial growth factor (VEGF) plays an important role in airway remodelling in various airway diseases such as idiopathic pulmonary fibrosis, pulmonary hypertension, lung cancer, asthma and chronic obstructive pulmonary disease (COPD). The effect of cigarette-smoking on VEGF expression, the modulatory role of extracellular signal-regulated kinase (ERK)-1,-2, p38mitogen-activated protein kinase (MAPK), histone acetylation and the anti-inflammatory effect of dexamethasone on TNFα-induced VEGF expression were examined in human airway smooth muscle cells (HASMC) of five non-smokers, 17 smokers without airflow limitation and 15 smokers with COPD. TNFα increased VEGF expression 5.4-fold and 4.0-fold in HASMC from non-smokers and smokers without airflow limitation, respectively, but only 2.5-fold in HASMC from smokers with COPD compared with non-stimulated HASMC. VEGF production was dependent on phosphorylation of ERK-1,-2 and p38MAPK, as was shown by examining the effects of PD 098059 (10 μM), an inhibitor of the upstream activator of MAPKkinase (MKK)-1, and SB 203580 (10 μM), an inhibitor of p38MAPK; there were no differences between non-smokers, smokers without airflow limitation and smokers with COPD in this respect. Dexamethasone (DEX; 10−12–10−4 M) reduced TNFα-induced phosphorylation of ERK-1/-2 and prevented TNFα-induced VEGF generation without differences between non-smokers, smokers with and without COPD. There was an additional inhibitory effect of DEX (10−12 M) on VEGF-release when PD 098059 was added. The basal and TNFα-induced acetylation status of the VEGF-promoter (chromatin immunoprecipitation [ChIP] assay) was increased in HASMC from smokers with COPD compared with smokers without airflow limitation and non-smokers. In comparison to non-stimulated HASMC, TNFα decreased the acetylation status of the VEGF-promoter by ∼46% and ∼43% in HASMC from non-smokers and smokers without COPD compared with ∼68% in HASMC from smokers with COPD. The data suggest that HASMC express VEGF in response to TNFα and that this may be reduced in HASMC of smokers with COPD in a smoking-independent manner. VEGF expression is directly modulated by phosphorylation of ERK-1,-2 and p38MAPK and by histone acetylation and the acetylation status of the VEGF gene is increased in HASMC of smokers with COPD in a smoking-independent manner. TNFα reduced the acetylation status of the VEGF promoter in HASMC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

VEGF:

Vascular endothelial growth factor

HASMC:

Human airway smooth muscle cells

ERK-1,-2:

Extracellular signal-regulated proteinkinase-1,-2

p38MAPK :

p38 Mitogen-activated proteinkinase

ChIP:

Chromatin immunoprecipitation

DEX:

Dexamethasone

COPD:

Chronic obstructive pulmonary disease

FEV1 :

Forced expiratory volume in 1 s

FVC:

Forced vital capacity

BAL:

Broncho-alveolar lavage

HAT:

Histone-acetyltransferase

HDAC:

Histone-deacetylase

References

  1. Papaioannou, A. I., Kostikas, K., Kollia, P., & Gourgoulianis, K. I. (2006). Clinical implications for vascular endothelial growth factor in the lung: Friend or foe? Respiratory Research, 7, 128.

    Article  PubMed  CAS  Google Scholar 

  2. Ferrara, N., & Davis-Smyth, T. (1997). The biology of vascular endothelial growth factor. Endocrine Reviews, 18(1), 4–25.

    Article  PubMed  CAS  Google Scholar 

  3. Melter, M., Reinders, M. E., Sho, M., Pal, S., Geehan, C., Denton, M. D., Mukhopadhyay, D., & Briscoe, D. M. (2000). Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood, 96(12), 3801–3808.

    PubMed  CAS  Google Scholar 

  4. Freeman, M. R., Schneck, F. X., Gagnon, M. L., Corless, C., Soker, S., Niknejad, K., Peoples, G. E., & Klagsbrun, M. (1995). Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis. Cancer Research, 55(18), 4140–4145.

    PubMed  CAS  Google Scholar 

  5. Ito, Y., Betsuyaku, T., Nagai, K., Nasuhara, Y., & Nishimura, M. (2005). Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury. Experimental Gerontology, 40(4), 315–323.

    Article  PubMed  CAS  Google Scholar 

  6. Acarregui, M. J., Penisten, S. T., Goss, K. L., Ramirez, K., & Snyder, J. M. (1999). Vascular endothelial growth factor gene expression in human fetal lung in vitro. American Journal of Respiratory Cell and Molecular Biology, 20(1), 14–21.

    PubMed  CAS  Google Scholar 

  7. Thickett, D. R., Armstrong, L., Christie, S. J., & Millar, A. B. (2001). Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine, 164(9), 1601–1605.

    PubMed  CAS  Google Scholar 

  8. Thickett, D. R., Armstrong, L., & Millar, A. B. (2002). A role for vascular endothelial growth factor in acute and resolving lung injury. American Journal of Respiratory and Critical Care Medicine, 166(10), 1332–1337.

    Article  PubMed  Google Scholar 

  9. Kanazawa, H., Eguchi, Y., Nomura, N., & Yoshikawa, J. (2005). Analysis of vascular endothelial growth factor levels in induced sputum samples from patients with cough variant asthma. Annals of Allergy Asthma & Immunology, 95(3), 266–271.

    CAS  Google Scholar 

  10. Kranenburg, A. R., de Boer, W. I., Alagappan, V. K., Sterk, P. J., & Sharma, H. S. (2005). Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Thorax, 60(2), 106–113.

    Article  PubMed  CAS  Google Scholar 

  11. Kanazawa, H., Asai, K., Hirata, K., & Yoshikawa, J. (2003). Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. American Journal of Medicine, 114(5), 354–358.

    Article  PubMed  CAS  Google Scholar 

  12. Melder, R. J., Koenig, G. C., Witwer, B. P., Safabakhsh, N., Munn, L. L., & Jain, R. K. (1996). During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nature Medicine, 2(9), 992–997.

    Article  PubMed  CAS  Google Scholar 

  13. Kim, I., Moon, S. O., Kim, S. H., Kim, H. J., Koh, Y. S., & Koh, G. Y. (2001). Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. The Journal of Biological Chemistry, 276(10), 7614–7620.

    Article  PubMed  CAS  Google Scholar 

  14. Barleon, B., Sozzani, S., Zhou, D., Weich, H. A., Mantovani, A., & Marme, D. (1996). Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood, 87(8), 3336–3343.

    PubMed  CAS  Google Scholar 

  15. Neufeld, G., Cohen, T., Gengrinovitch, S., & Poltorak, Z. (1999). Vascular endothelial growth factor (VEGF) and its receptors. The FASEB Journal, 13(1), 9–22.

    PubMed  CAS  Google Scholar 

  16. Knox, A. J., Corbett, L., Stocks, J., Holland, E., Zhu, Y. M., & Pang, L. (2001). Human airway smooth muscle cells secrete vascular endothelial growth factor: Up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism. The FASEB Journal, 15(13), 2480–2488.

    Article  PubMed  CAS  Google Scholar 

  17. Nilsson, I., Shibuya, M., & Wennström, S. (2004). Differential activation of vascular genes by hypoxia in primary endothelial cells. Experimental Cell Research, 299(2), 476–485.

    Article  PubMed  CAS  Google Scholar 

  18. Wen, F. Q., Liu, X., Manda, W., Terasaki, Y., Kobayashi, T., Abe, S., Fang, Q., Ertl, R., Manouilova, L., & Rennard, S. I. (2003). TH2 cytokine-enhanced and TGF-beta-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFNγ and corticosteroids. The Journal of Allergy and Clinical Immunology, 111(6), 1307–1318.

    Article  PubMed  CAS  Google Scholar 

  19. Lukacs, N. W., Strieter, R. M., Chensue, S. W., Widmer, M., & Kunkel, S. L. (1995). TNFα mediates recruitment of neutrophils and eosinophils during airway inflammation. Journal of Immunology, 154(10), 5411–5417.

    CAS  Google Scholar 

  20. Howarth, P. H., Babu, K. S., Arshad, H. S., Lau, L., Buckley, M., McConnell, W., Beckett, P., Al Ali, M., Chauhan, A., Wilson, S. J., Reynolds, A., Davies, D. E., & Holgate, S. T. (2005). Tumour necrosis factor (TNF) alpha as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax, 60(12), 1012–1018.

    Article  PubMed  CAS  Google Scholar 

  21. Aaron, S. D., Angel, J. B., Lunau, M., Wright, K., Fex, C., Le Saux, N., & Dales, R. E. (2001). Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 163(2), 349–355.

    PubMed  CAS  Google Scholar 

  22. Mura, M., dos Santos, C. C., Stewart, D., & Liu, M. (2004). Vascular endothelial growth factor related molecules in acute lung injury. Journal of Applied Physiology, 97(5), 1605–1617.

    Article  PubMed  CAS  Google Scholar 

  23. Ferrara, N., Gerber, H. P., & LeCouter, J. T. (2003). The biology of VEGF and its receptors. Nature Medicine, 9(6), 669–676.

    Article  PubMed  CAS  Google Scholar 

  24. Guo, D., Jia, Q., Song, H. Y., Warren, R. S., & Donner, D. B. (1995). Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. The Journal of Biological Chemistry, 270(12), 6729–6733.

    Article  PubMed  CAS  Google Scholar 

  25. Eliceiri, B. P., Paul, R., Schwartzberg, P. L., Hood, J. D., Leng, J., & Cheresh, D. A. (1999). Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Molecular Cell, 4(6), 915–924.

    Article  PubMed  CAS  Google Scholar 

  26. Alagappan, V. K., McKay, S., Widyastuti, A., Garrelds, I. M., Bogers, A. J., Hoogsteden, H. C., Hirst, S. J., & Sharma, H. S. (2005). Proinflammatory cytokines upregulate mRNA expression and secretion of vascular endothelial growth factor in cultured human airway smooth muscle cells. Cell Biochemistry and Biophysics, 43(1), 119–129.

    Article  PubMed  CAS  Google Scholar 

  27. Cano, E., & Mahadevan, L. C. (1995). Parallel signal processing among mammalian MAPKs. Trends in Biochemical Sciences, 20(3), 117–122.

    Article  PubMed  CAS  Google Scholar 

  28. Vanden Berghe, W., De Bosscher, K., Boone, E., Plaisance, S., & Haegeman, G. (1999). The nuclear factor-kappa B engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. The Journal of Biological Chemistry, 274(45), 32091–32098.

    Article  Google Scholar 

  29. Ait-Si-Ali, S., Carlisi, D., Ramirez, S., Upegui-Gonzalez, L. C., Duquet, A., Robin, P., Rudkin, B., Harel-Bellan, A., & Trouche, D. (1999). Phosphorylation by p44 MAP kinase/ERK-1 stimulates CBP histone acetyl transferase activity in vitro. Biochemical and Biophysical Research Communications, 262(1), 157–162.

    Article  PubMed  CAS  Google Scholar 

  30. Koch, A., Giembycz, M., Ito, K., Lim, S., Jazrawi, E., Barnes, P. J., Adcock, I., Erdmann, E., & Chung, K. F. (2004). Mitogen-activated protein kinase modulation of nuclear factor-κB-induced granulocyte macrophage-colony-stimulating factor release from human alveolar macrophages. American Journal of Respiratory Cell and Molecular Biology, 30(3), 342–349.

    Article  PubMed  CAS  Google Scholar 

  31. Fabbri, L., Pauwels, R. A., & Hurd, S. S. (2004). Gold Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary updated 2003. COPD, 1, 105–141.

    Article  PubMed  Google Scholar 

  32. Pauwels, R. A., Buist, A. S., Calverley, P. M., Jenkins, C. R., & Hurd, S. S. (2001). GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. American Journal of Respiratory and Critical Care Medicine, 163(5), 1256–1276.

    PubMed  CAS  Google Scholar 

  33. American Thoracic Society. (1995). Standardization of spirometry, 1994 update. American Journal of Respiratory and Critical Care Medicine, 152(3), 1107–1136.

    Google Scholar 

  34. Goldman, H. I., & Becklake, M. R. (1959). Respiratory function tests; normal values at median altitudes and the prediction of normal results. American Review of Tuberculosis, 79(4), 457–467.

    PubMed  CAS  Google Scholar 

  35. Oltmanns, U., Issa, R., Sukkar, M. B., John, M., & Chung, K. F. (2003). Role of c-jun N-terminal kinase in the induced release of GM-CSF, RANTES and IL-8 from human airway smooth muscle cells. British Journal of Pharmacology, 139(6), 1228–1234.

    Article  PubMed  CAS  Google Scholar 

  36. Ito, K., Ito, M., Elliott, W. M., Cosio, B., Caramori, G., Kon, O. M., Barczyk, A., Hayashi, S., Adcock, I. M., Hogg, J. C., & Barnes, P. J. (2005). Decreased histone deacetylase activity in chronic obstructive pulmonary disease. The New England Journal of Medicine, 352(19), 1967–1976.

    Article  PubMed  CAS  Google Scholar 

  37. Nagai, K., Betsuyaku, T., Ito, Y., Nasuhara, Y., & Nishimura, M. (2005). Decrease of vascular endothelial growth factor in macrophages from long-term smokers. The European Respiratory Journal, 25(4), 626–633.

    Article  PubMed  CAS  Google Scholar 

  38. Marwick, J. A., Stevenson, C. S., Giddings, J., MacNee, W., Butler, K., Rahman, I., & Kirkham, P. A. (2006). Cigarette smoke disrupts VEGF165-VEGFR-2 receptor signaling complex in rat lungs and patients with COPD: Morphological impact of VEGFR-2 inhibition. American Journal of Physiolgy. Lung Cell and Molecular Physiology, 290(5), L897–L908.

    Article  CAS  Google Scholar 

  39. Christou, H., Yoshida, A., Arthur, V., Morita, T., & Kourembanas, S. (1998). Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. American Journal of Respiratory Cell and Molecular Biology, 18(6), 768–776.

    PubMed  CAS  Google Scholar 

  40. Takagi, H., King, G. L., Ferrara, N., & Aiello, L. P. (1996). Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Investigative Ophtalmology & Visual Science, 37(7), 1311–1321.

    CAS  Google Scholar 

  41. Elias, J. A., Kang, M. J., Crouthers, K., Homer, R., & Lee, C. G. (2006). Mechanistic heterogeneity in chronic obstructive pulmonary disease: Insights from transgenic mice. Proceedings of the American Thoracic Society, 3(6), 494–498.

    Article  PubMed  CAS  Google Scholar 

  42. Calabrese, C., Bocchino, V., Vatrella, A., Marzo, C., Guarino, C., Mascitti, S., Tranfa, C. M., Cazzola, M., Micheli, P., Caputi, M., & Marsico, S. A. (2006). Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction. Respiratory Medicine, 100(8), 1415–1422.

    Article  PubMed  Google Scholar 

  43. Kasahara, Y., Tuder, R. M., Taraseviciene-Stewart, L., Le Cras, T. D., Abman, S., Hirth, P. K., Waltenberger, J., & Voelkel, N. F. (2000). Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. The Journal of Clinical Investigation, 106(11), 1311–1319.

    PubMed  CAS  Google Scholar 

  44. Tang, J. R., Markham, N. E., Lin, Y. J., McMurtry, I. F., Maxey, A., Kinsella, J. P., & Abman, S. H. (2004). Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. American Journal of Physiolgy. Lung Cell and Molecular Physiology, 287(2), L344–L351.

    Article  CAS  Google Scholar 

  45. Lee, K. S., Min, K. H., Kim, S. R., Park, S. J., Park, H. S., Jin, G. Y., & Lee, Y. C. (2006). Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma. American Journal of Respiratory and Critical Care Medicine, 174(2), 161–170.

    Article  PubMed  CAS  Google Scholar 

  46. Ito, K., Lim, S., Caramori, G., Chung, K. F., Barnes, P. J., & Adcock, I. M. (2001). Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. The FASEB Journal, 15(6), 1110–1112.

    PubMed  CAS  Google Scholar 

  47. Malo, M. S., Biswas, S., Abedrapo, M. A., Yeh, L., Chen, A., & Hodin, R. A. (2006). The pro-inflammatory cytokines, IL-1beta and TNF-alpha, inhibit intestinal alkaline phosphatase gene expression. DNA Cell Biology, 25(12), 684–695.

    Article  CAS  Google Scholar 

  48. Lee, J. Y., Kim, N. A., Sanford, A., & Sullivan, K. E. (2003). Histone acetylation and chromatin conformation are regulated separately at the TNFα promoter in monocytes and macrophages. Journal of Leukocyte Biology, 73(6), 862–871.

    Article  PubMed  CAS  Google Scholar 

  49. Sakao, S., Tatsumi, K., Hashimoto, T., Igari, H., Shino, Y., Shirasawa, H., & Kuriyama, T. (2003). Vascular endothelial growth factor and the risk of smoking-related COPD. Chest, 124(1), 323–327.

    Article  PubMed  CAS  Google Scholar 

  50. Keatings, V. M., Collins, P. D., Scott, D. M., & Barnes, P. J. (1996). Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. American Journal of Respiratory and Critical Care Medicine, 153(2), 530–534.

    PubMed  CAS  Google Scholar 

  51. Mal, H. (2007). Prevalence and diagnosis of severe pulmonary hypertension in patients with chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine, 13(2), 114–119.

    Article  PubMed  Google Scholar 

  52. Duyndam, M. C., Hulscher, S. T., van der Wall, E., Pinedo, H. M., & Boven, E. (2003). Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite. The Journal of Biological Chemistry, 278(9), 6885–6895.

    Article  PubMed  CAS  Google Scholar 

  53. Sauer, H., Bekhite, M. M., Hescheler, J., & Wartenberg, M. (2005). Redox control of angiogenic factors and CD31-positive vessel-like structures in mouse embryonic stem cells after direct current electrical field stimulation. Experimental Cell Research, 304(2), 380–390.

    Article  PubMed  CAS  Google Scholar 

  54. Wang, F. S., Wang, C. J., Chen, Y. J., Chang, P. R., Huang, Y. T., Sun, Y. C., Huang, H. C., Yang, Y. J., & Yang, K. D. (2004). Ras induction of superoxide activates ERK-dependent angiogenic transcription factor HIF-1α and VEGF-A expression in shock wave-stimulated osteoblasts. The Journal of Biological Chemistry, 279(11), 10331–10337.

    Article  PubMed  CAS  Google Scholar 

  55. Wang, M., Crisostomo, P. R., Herring, C., Meldrum, K. K., & Meldrum, D. R. (2006). Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. American Journal of Physiology. Regulatory, Integrative and Comparitive Physiology, 291(4), R880–R884.

    CAS  Google Scholar 

  56. Demirjian, L., Abboud, R. T., Li, H., & Duronio, V. (2006). Acute effect of cigarette smoke on TNFα release by macrophages mediated through the ERK-1/-2 pathway. Biochimica et Biophysica Acta, 1762(6), 592–597.

    PubMed  CAS  Google Scholar 

  57. Tran, T., Fernandes, D. J., Schuliga, M., Harris, T., Landells, L., & Stewart, A. G. (2005). Stimulus-dependent glucocorticoid-resistance of GM-CSF production in human cultured airway smooth muscle. British Journal of Pharmacology, 145, 123–131.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrea Koch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raidl, M., Sibbing, B., Strauch, J. et al. Impaired TNFα-induced VEGF Expression in Human Airway Smooth Muscle Cells from Smokers with COPD: Role of MAPkinases and Histone Acetylation—Effect of Dexamethasone. Cell Biochem Biophys 49, 98–110 (2007). https://doi.org/10.1007/s12013-007-0043-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-007-0043-4

Keywords

Navigation